v3.20.2
Consolidated Balance Sheets - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Current Assets    
Cash and cash equivalents $ 24,808,083 $ 9,039,887
Short-term investments 92,501,019 5,713,922
Accounts receivable 212,141 34,986
Prepaid expenses and other current assets 1,620,504 420,328
Total Current Assets 119,141,747 15,209,123
Property and Equipment, net 720,396 559,410
Other Assets    
In-process R&D 5,866,000 5,866,000
Goodwill 1,452,338 1,452,338
Operating lease right-of-use asset 2,123,414 2,287,500
Finance lease right-of-use asset 276,918 187,573
Deposits 129,505 394,637
Total Other Assets 9,848,175 10,188,048
Total Assets 129,710,318 25,956,581
Current Liabilities    
Accounts payable 753,872 1,503,342
Deferred revenue, current portion 1,166,481 3,410,319
Contingent consideration, current portion   1,124,970
Contingent consideration, related party - current portion   454,364
Operating lease liability, current portion 271,703 216,832
Finance lease liability, current portion 106,409 49,104
Accrued expenses and other liabilities 1,503,899 1,676,467
Total Current Liabilities 3,802,364 8,435,398
Long Term Liabilities    
Other long-term liabilities 26,331  
Derivative warrant liability 60,915  
Deferred tax liability 361,911 361,911
Deferred revenue, net of current portion 240,000 200,000
Operating lease liability, net of current portion 1,374,141 1,519,574
Financing lease liability, net of current portion 187,881 142,667
Contingent consideration, net of current portion 2,131,830 1,653,197
Contingent consideration, related party - net of current portion 626,685 485,984
Total Liabilities 8,812,058 12,798,731
Commitments and Contingencies (Note 13)
Stockholders' Equity    
Common stock, $.0002 par value; 250,000,000 shares authorized, 157,021,194 and 33,785,999 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively 31,402 6,757
Additional paid-in capital 245,740,939 118,173,843
Accumulated deficit (124,195,893) (104,597,748)
Accumulated other comprehensive loss (35,910) (11,250)
Total Stockholders' Equity - Heat Biologics, Inc. 121,540,538 13,571,602
Non-Controlling Interest (642,278) (413,752)
Total Stockholders' Equity 120,898,260 13,157,850
Total Liabilities and Stockholders' Equity $ 129,710,318 $ 25,956,581

Source